![](https://testing.innoplexus.com/wp-content/plugins/relevant/images/no_preview.jpg)
Ontosight® – Biweekly NewsletterJune 17th – June 30th, 2024 –Read More
Ontosight® – Biweekly NewsletterJune 17th – June 30th, 2024 –Read More
May 24
Apr 24
Innoplexus wins Horizon Interactive Gold Award for Curia App
Read MoreTherapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Oncology | Solid tumors | AKAP-4 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Verik bio |
Oncology | Pancreatic cancer | PI3K | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Oncology | Multiple oncology indications | MetAP2 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Multiple oncology indications | OX40 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Pancreatic cancer | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Oncology and Inflammatory diseases | Confidential | PIM family | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Inflection Biosciences |
Immunology | Multiple immunology indications | IL-17 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Inflammatory disorders | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Neurodegenerative diseases | Alzhiemers disease | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio alpha |
Mental health disorders | Depression | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Anxiety | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Sleep disorder | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | ADHD | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Opoid abuse | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Schizophrenia | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Sensori-neural diseases | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Metabolic diseases | T1D and co-morbidities | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Cardiology | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Dermatology + others | Confidential | TLR | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Dermatology | Confidential | TLR | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Dermatology | Confidential | TLR | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Infectious diseases | Antimicrobial resistance | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio beta |
Infectious diseases | Covid-19 | 3CLPro | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Pain related indications | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
ICU treatment | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Rare diseases | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Rare diseases | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Multiple TAs | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Oncology | Solid tumors | AKAP-4 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Verik bio |
Oncology | Pancreatic cancer | PI3K | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Oncology | Multiple oncology indications | MetAP2 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Multiple oncology indications | OX40 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Pancreatic cancer | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Oncology and Inflammatory diseases | Confidential | PIM family | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Inflection Biosciences |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Immunology | Multiple immunology indications | IL-17 | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Inflammatory disorders | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Neurodegenerative diseases | Alzhiemers disease | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio alpha |
Mental health disorders | Depression | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Anxiety | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Sleep disorder | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | ADHD | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Opoid abuse | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Schizophrenia | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Sensori-neural diseases | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Metabolic diseases | T1D and co-morbidities | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Cardiology | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Dermatology + others | Confidential | TLR | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Dermatology | Confidential | TLR | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Dermatology | Confidential | TLR | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Infectious diseases | Antimicrobial resistance | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio beta |
Infectious diseases | Covid-19 | 3CLPro | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Pain related indications | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
ICU treatment | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Rare diseases | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Rare diseases | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Multiple TAs | Confidential | Confidential | Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Oncology | Solid tumors | AKAP-4 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Verik bio |
Oncology | Pancreatic cancer | PI3K | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Oncology | Multiple oncology indications | MetAP2 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Multiple oncology indications | OX40 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Pancreatic cancer | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Oncology and Inflammatory diseases | Confidential | PIM family | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Inflection Biosciences |
Immunology | Multiple immunology indications | IL-17 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Inflammatory disorders | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Neurodegenerative diseases | Alzhiemers disease | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio alpha |
Mental health disorders | Depression | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Anxiety | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Sleep disorder | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | ADHD | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Opoid abuse | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Schizophrenia | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Sensori-neural diseases | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Metabolic diseases | T1D and co-morbidities | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Cardiology | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Dermatology + others | Confidential | TLR | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Dermatology | Confidential | TLR | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Dermatology | Confidential | TLR | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Infectious diseases | Antimicrobial resistance | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio beta |
Infectious diseases | Covid-19 | 3CLPro | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Pain related indications | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
ICU treatment | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Rare diseases | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Rare diseases | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Multiple TAs | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Oncology | Solid tumors | AKAP-4 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Verik bio |
Oncology | Pancreatic cancer | PI3K | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Oncology | Multiple oncology indications | MetAP2 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Multiple oncology indications | OX40 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Oncology | Pancreatic cancer | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Oncology and Inflammatory diseases | Confidential | PIM family | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Inflection Biosciences |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Immunology | Multiple immunology indications | IL-17 | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Cureteq |
Inflammatory disorders | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Inflammatory disorders | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Neurodegenerative diseases | Alzhiemers disease | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio alpha |
Mental health disorders | Depression | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Anxiety | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Sleep disorder | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | ADHD | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Opoid abuse | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Mental health disorders | Schizophrenia | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Sensori-neural diseases | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Metabolic diseases | T1D and co-morbidities | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Cardiology | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Dermatology + others | Confidential | TLR | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Dermatology | Confidential | TLR | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Dermatology | Confidential | TLR | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Infectious diseases | Antimicrobial resistance | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Discoveric bio beta |
Infectious diseases | Covid-19 | 3CLPro | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Land of Hessen |
Pain related indications | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
ICU treatment | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | DrD |
Therapeutic Area | Indication | Target | Stage | Partner |
---|---|---|---|---|
Rare diseases | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Rare diseases | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Multiple TAs | Confidential | Confidential | Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch | Confidential |
Cookie | Duration | Description |
---|---|---|
cookie-checkbox-analytics | 11 months | The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookie-checkbox-functional | 11 months | The cookie is set to record the user consent for the cookies in the category "Functional". |
cookie-checkbox-necessary | 11 months | The cookies are used to store the user consent for the cookies in the category "Necessary". |
cookie-checkbox-others | 11 months | This cookie is used to store the user consent for the cookies in the category "Other. |
cookie-checkbox-performance | 11 months | The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is used to store whether or not a user has consented to the use of cookies. It does not store any personal data. |